Monika Russel-Szymczyk

Statistics

Publications

Citations

H-Index

Active since

2018

Affiliations

Freiwillige Akademische Gesellschaft(Current)

Monika Russel-Szymczyk is an author at Freiwillige Akademische Gesellschaft specializing in diabetes mellitus, cost-effectiveness comparison, and glycemic control.

ORCID

Publications per year

2018–2019

Publications

Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes: A Long-Term Cost-Effectiveness Analysis in Estonia

Samuel J. P. Malkin, Monika Russel-Szymczyk, Girtel Liidemann et al. · Diabetes Therapy · 2018 · 17 citations · Full text

Pharmacy, Endocrinology, Pharmacotherapy +17

Treating Patients with Type 2 Diabetes Mellitus Uncontrolled on Basal Insulin in the Czech Republic: Cost-Effectiveness of IDegLira Versus iGlarLixi

Johannes Pöhlmann, Monika Russel-Szymczyk, Pavel Holík et al. · Diabetes Therapy · 2019 · 15 citations · Full text

Medicine, Endocrinology, Pharmacoeconomics +17

The Management of Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide: A Long-Term Cost-Effectiveness Analysis in Slovakia

Samuel J. P. Malkin, Monika Russel-Szymczyk, Marek Psota et al. · Advances in Therapy · 2019 · 14 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U100 in Patients with Type 1 and Type 2 Diabetes Mellitus in Serbia

Nebojša Lalić, Monika Russel-Szymczyk, Marina Culic et al. · Diabetes Therapy · 2018 · 10 citations · Full text

Pharmacy, Internal Medicine, Pharmacoeconomics +17

1–4 of 4